Skip to main content

Table 3 Quantification of the immunostaining by the integrated pixel density – ratio ipsi/contralateral (%)

From: Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair

Antibody

Anti-VGLUT1

Anti-S100

Anti-neurofilament

Anti-ChAT

N (norm)

66.19 ± 7.752

150.6 ± 15.67

35.18 ± 2.189

47.66 ± 5.526

N + F

57.04 ± 9.484

100.5 ± 9.04

29.51 ± 3.091

50.26 ± 7.681

N + F + D

54.36 ± 6.536

80.04 ± 6.90

38.15 ± 2.819

48.95 ± 5.090

N + F + W

73.84 ± 6.312

96.24 ± 4.91

35.18 ± 3.739

53.51 ± 7.145

N + F + T

81.91 ± 10.41

131.5 ± 16.37

39.56 ± 1.682

56.79 ± 6.056

N + F + D + T

107.3 ± 15.88

99.7 ± 12.42

39.30 ± 4.336

61.13 ± 5.792

  1. N neurorrhaphy, F heterologous fibrin sealant, D doxycycline, W wild-type hESCs, T transgenic hESCs